Medical News

RSS

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.

21 Sep 2011

Influential leaders hold high-level discussions on biomedical S&T initiatives

Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.

21 Sep 2011

New FDA-approved antiviral drugs offer treatment hope for hepatitis C

The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.

21 Sep 2011

Study reveals possible new treatment targets for diffuse intrinsic pontine gliomas

Study led by St. Jude Children's Research Hospital scientists points to possible new treatment targets for diffuse intrinsic pontine gliomas; may tip the scales in the current debate about tumor biopsies.

21 Sep 2011

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

GI Dynamics, Inc. today announced the launch of the EndoBarrier Gastrointestinal Liner in Austria, the establishment of the first two Centers of Excellence and the treatment of patients at each new Center.

21 Sep 2011

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that in a rodent contusion model of SCI the Company's proprietary biopolymer scaffold showed positive preliminary data that indicate a therapeutic effect.

21 Sep 2011

MRI screenings for breast cancer benefit high-risk, underserved women

Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general risk mammography screenings.

21 Sep 2011

FDA clears Toshiba's advanced M-Power interface

Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.

21 Sep 2011

NUI Galway researchers develop super-sized model of heart valve

Researchers at NUI Galway have developed a super-sized model of a heart valve which may lead to a new generation of cardiovsacular devices.

21 Sep 2011

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

A free public lecture at the University of Leicester is to discuss how the white matter of the brain could be the key to understanding and treating brain disorders - not grey matter as previously thought.

21 Sep 2011

Gothenburg researcher advises patients with acute low back pain to stay active

Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Boehringer Ingelheim today announced enrolment has commenced in its TOviTO Phase III clinical trial program. It will investigate tiotropium plus olodaterol in a once-daily fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

21 Sep 2011

UTHealth doctoral student receives ASM, NIH research fellowships for E. coli study

A doctoral student at The University of Texas Health Science Center at Houston (UTHealth) has been awarded two research fellowships to study the spread of E. coli, a hard-to-treat bacterium that can lead to food poisoning.

21 Sep 2011

Foreign Affairs examines history of negotiations on NCD political declaration

Foreign Affairs on Tuesday published an analysis examining the history of negotiations behind the political declaration approved on Monday by leaders attending the U.N. High-level Meeting on Non-Communicable Diseases.

21 Sep 2011

Researchers discover how living organisms avoid CO poisoning

Scientists have discovered how living organisms - including humans - avoid poisoning from carbon monoxide generated by natural cell processes.

From The University of Manchester 21 Sep 2011

MedPAC offers possible offsets for Medicare physician pay fix

Still, Obama's deficit-reduction plan, released yesterday, includes no funding for the doc fix. Some are eyeing a Medicaid adjustment that will garner $13 billion in savings as a possible cash cow - but competition is stiff for these funds.

21 Sep 2011

St. Jude Medical pledges $100,000 to support SIR Foundation's Discovery Campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. St. Jude Medical Foundation, the philanthropic arm of St. Jude Medical, has pledged $100,000 and is a "Pioneer" level supporter.

21 Sep 2011

GOP presidential hopeful Rick Perry's record on women's health scrutinized

As the GOP presidential primary campaign continues to heat up, news outlets focus on Texas Gov. Rick Perry's state policy record: An NPR report today examines his funding for women's health. Meanwhile, Michele Bachmann offers her take on employer-sponsored health insurance.

21 Sep 2011

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd., today announced an agreement to expand Bristol-Myers Squibb's territorial rights to develop and commercialize the anti-PD-1 antibody known as BMS-936558/ONO-4538, and to create a strategic alliance for the co-development and co-commercialization of ORENCIA in Japan.

21 Sep 2011